About us | About Scoope | Contact us

 Sponsor Links
| Articles | White Papers | Presentations 

Articles                                                                                                  TOP

Drug companies skew trial data to trick the public

(naturalnews.com): Tampering with drug trials is nothing new for the pharmaceutical industry, but recent reports explain just how far drug companies are willing to go to make an ineffective, unsafe drug look safe and effective. A recent BBC report explains that in many countries, drug companies are not even required to publish all safety study data when submitting to journals, so they typically submit only the ones that appear positive while burying the negative ones.
Click here

An evidence-based call to get pharma out of medical education

(blogs.crikey.com.au): A team of researchers from Australia, Canada and Malaysia has published a systematic review investigating the impact of pharmaceutical promotions in the online journal PLoS Medicine. The editor's summary of the review concludes that the findings support the case for reforms to reduce negative influence to prescribing from pharmaceutical promotion.
Click here

We Thought The Internet Was Killing Print-But It Isn't

(paidcontent.org): The Guardian, Times and Telegraph are all down by around a third, and the Sun has lost more than a million: but again there's no mechanical relationship here. Price matters. It always does. But investment and innovation matter as well. They always do. And you can't help by being struck how little of that goes on in print these days.
Click here

Many Scientific Reports Plagiarsed

(ipsnews.net): Embarrassing retractions of scientific papers and a thinly-disguised report favouring introduction of genetically modified crops by the country's top science academies have revived calls for more stringent action against plagiarism and unethical practices. India's scientific community professed shock to see three retraction notices published in the November-December 2010 issue of 'Biotechnology Advances', a prestigious international scientific journal, against three papers presented to it by Indian scientists..
Click here

New evidence of the power of open access

(eurekalert.org): New findings settle one of the arguments about Open Access (OA) research publications: Are they more likely to be cited because they were made OA, or were they made OA because they were more likely to be cited? The study, which will be published in PLoS ONE on the first day of Open Access Week (18 October), shows that the OA citation impact advantage is just as great when OA is mandatory (i.e., the author's institution or funder requires the author to make all research publications OA) as it is when OA is optional (i.e., the author self-selects whether and what to make OA).
Click here

For banner ads click here